Human medicines European public assessment report (EPAR): Orladeyo, berotralstat, Date of authorisation: 30/04/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Anzupgo, delgocitinib, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised

Class III implantable devices and Class IIb medical devices intended to administer or remove medicinal products: expert panel opinions

Vascular and cardiac prostheses – other - Notified Bodfy 0344 - 25/11/2025 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

General medicine therapeutic treatment instruments - Notified Body 2797 - 12/05/2026 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Human medicines European public assessment report (EPAR): Libmeldy, autologous CD34+ cells encoding ARSA gene, Date of authorisation: 17/12/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Cavoley, pegfilgrastim, Date of authorisation: 25/09/2026, Status: Authorised

Minutes - HMA-EMA joint Network Data Steering Group meeting - 10 September 2026

Minutes - HMA-EMA joint Network Data Steering Group meeting - 17 July 2026

Guidance on good manufacturing practice and good distribution practice: Questions and answers